Collegium Pharmaceutical, Inc. COLL Contract Liabilities
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s contract liabilities?
- Collegium Pharmaceutical, Inc. (COLL) reported contract liabilities of $8.94M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s contract liabilities changed year-over-year?
- Collegium Pharmaceutical, Inc.'s contract liabilities decreased by 10.6% year-over-year, from $10M to $8.94M.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.